Skip to main content
SpringerLink
Log in

Afatinib/osimertinib

Grade-3 interstitial lung diseases and rash: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sato Y, et al. Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report. Respiratory Medicine Case Reports 33: 101450, Jan 2021. Available from: URL: http://doi.org/10.1016/j.rmcr.2021.101450

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib/osimertinib. Reactions Weekly 1866, 21 (2021). https://doi.org/10.1007/s40278-021-99717-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-99717-9

Search

Navigation